Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
TME Pharma N.V.
ALTMECurrent price
0.15 EUR
+0.0071 EUR (+4.79%)
Last closed
0.14 EUR
Company
www.tmepharma.com
ISIN
NL0012044762
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
6 240 108 EUR
Yield for 12 month
-60.93 %
1Y
3Y
5Y
10Y
15Y
ALTME
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. The company is also developing NOX-E36, which has completed Phase 1/2 clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. in July 2022. TME Pharma N.V. was founded in 1997 and is headquartered in Berlin, Germany. Address: Max-Dohrn-Strasse 8-10, Berlin, Germany, 10589
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.47 EURP/E ratio
–Dividend Yield
–Current Year
+17 250 EUR
Last Year
–
Current Quarter
–
Last Quarter
+8 625 EUR
Current Year
-128 866 EUR
Last Year
-93 352 EUR
Current Quarter
-66 969 EUR
Last Quarter
+8 625 EUR
Key Figures ALTME
1 year
3 years
5 years
10 years
EBITDA
-5 673 145 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-109.5 %
PEG Ratio
–
Return On Equity TTM
-901 %
Wall Street Target Price
0.47 EUR
Revenue TTM
-27 397 EUR
Book Value
0.038 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-90.9 %
Dividend Yield
–
Gross Profit TTM
33 485 EUR
Earnings per share
-0.48 EUR
Diluted Eps TTM
-0.48 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALTME
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALTME
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
28.07.2022
Dividend Date
–
Stock Valuation ALTME
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
1.0715
Enterprise Value Revenue
–
Price Sales TTM
321.8223
Enterprise Value EBITDA
0.3952
Price Book MRQ
4.2471
Financials ALTME
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALTME
For 52 weeks
0.11 EUR
0.44 EUR
50 Day MA
0.14 EUR
Shares Short Prior Month
–
200 Day MA
0.21 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart